Role of Mitochondrial CYP2E1 in Chemical Exposure-Driven Neurodegeneration
Role of Mitochondrial CYP2E1 in Chemical Exposure-Driven Neurodegeneration
批准号:
9189444
负责人:
Jessica Helene Hartman
金额:
$5.25万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-08-01 至 2019-07-31
关键词:
AffectAgeBiological AssayBullaCYP2E1 geneCaenorhabditis elegansCell DeathCellsCessation of lifeChemical ExposureClinicalDevelopmentDisease ProgressionEarly DiagnosisEndoplasmic ReticulumEnvironmentEnvironmental PollutantsEnvironmental Risk FactorExposure toFellowshipFluorescence MicroscopyFunctional disorderGeneticGenetic RiskGenus HippocampusGoalsHealthHepatocyteHumanIn SituInterventionKnowledgeLeadLifeLinkLiverLongevityMeasurementMeasuresMembrane PotentialsMetabolic ActivationMetabolismMethanolMitochondriaMitochondrial DNAMitochondrial ProteinsModelingMutationNematodaNerve DegenerationNeurodegenerative DisordersNeuronsOrganellesPC12 CellsParkinson DiseasePathogenesisPersonsPesticidesPharmaceutical PreparationsPlayPopulationPreventive measureResearchRespirationRisk AssessmentRisk FactorsRoleSolventsSubstantia nigra structureSymptomsTestingToxic Environmental SubstancesToxic effectToxicant exposureTransgenic OrganismsTrichloroethyleneUnited States National Institutes of HealthWhole Organismabstractingbasecell injurydopaminergic neuronimprovedin vivoinstrumentmitochondrial dysfunctionmitochondrial membranenervous system disorderneuron lossneuroprotectionparkin gene/proteinprophylacticresearch studyrespiratory proteinsmall moleculetargeted treatmenttherapeutic targettoxicant
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
Parkinson's Disease (PD) is one of the most common neurodegenerative disorders, affecting >1% of the
population over age 60. PD pathophysiology includes preferential loss of dopaminergic neurons in the
substantia nigra (SN), and has been linked to both genetic and environmental risk factors. However, genetics
can only explain 5-10% of late-onset cases, so environment may play a larger role in most cases. PD has been
demonstrated at the cellular level to involve mitochondrial dysfunction. Multiple environmental toxicants known
to be toxic to mitochondria require metabolic activation to exert this toxicity through reactive metabolites that
damage vulnerable mitochondrial proteins and DNA. Two well-known examples of metabolically activated
compounds are trichloroethylene, a pervasive environmental pollutant, and methanol, a common solvent and
fuel additive; both trichloroethylene and methanol are activated by cytochrome P450 2E1 (CYP2E1). CYP2E1
has traditionally been studied in the endoplasmic reticulum (ER) of liver hepatocytes; however, it is also
expressed in SN dopaminergic neurons. Moreover, CYP2E1 is bimodally targeted to ER and mitochondria in
those cells. Relatively little is known about the consequence of mitochondrial CYP2E1 localization on
mitochondrial integrity and/or function and ultimately pathogenesis of neurodegenerative diseases.
This NIH postdoctoral fellowship proposal will assess the role of mitochondrial CYP2E1 (mtCYP2E1) in
mitochondrial dysfunction and neurodegeneration due to the activation of trichloroethylene and methanol in
transgenic human CYP2E1-expressing PC-12 cells and C. elegans (in vivo). We hypothesize that activation
of these toxicants by CYP2E1 within mitochondrial organelles will cause localized damage that triggers
mitochondrial dysfunction and drives neurodegeneration. To test this hypothesis, mitochondrial
dysfunction will be assessed in cells and in vivo through a battery of mitochondrial assays including whole-cell
and whole-organism respiration assays using a Seahorse XF instrument, ATP measurements, and
assessment of mitochondrial membrane potential. Neurodegeneration induced by methanol and
trichloroethylene will be assessed in vivo by fluorescence microscopy of live C. elegans nematodes bearing
GFP-tagged neurons. Overall, knowledge gained from this study will aid in development of more accurate risk
assessments for neurodegeneration triggered by exposures to environmental toxicants and could provide new
targets for intervention and/or neuroprotection. The following aims will be pursued:
Specific Aim 1: Determine CYP2E1-dependent mitochondrial dysfunction induced by toxicants.
Specific Aim 2: Assess the role of mitochondrial CYP2E1 in toxicant-induced neurodegeneration.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Subcellular-targeted CYP2E1 and alcohol in the brain
-
批准号:10496067
-
项目类别:
-
资助金额:$35.45万
-
财政年份:2023
-
负责人:Jessica Helene Hartman
-
依托单位:
Regulation and Consequences of Cytochrome P450 2E1
-
批准号:10713697
-
项目类别:
-
资助金额:$36.89万
-
财政年份:2023
-
负责人:Jessica Helene Hartman
-
依托单位:
Exercise, MANF, and Chemical-Induced Neurodegeneration
-
批准号:10380263
-
项目类别:
-
资助金额:$2.08万
-
财政年份:2021
-
负责人:Jessica Helene Hartman
-
依托单位:
Exercise, MANF, and Chemical-Induced Neurodegeneration
-
批准号:10307629
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2020
-
负责人:Jessica Helene Hartman
-
依托单位:
Exercise, MANF, and Chemical-Induced Neurodegeneration
-
批准号:10513154
-
项目类别:
-
资助金额:$4.9万
-
财政年份:2020
-
负责人:Jessica Helene Hartman
-
依托单位:
Exercise, MANF, and Chemical-Induced Neurodegeneration
-
批准号:10513823
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2020
-
负责人:Jessica Helene Hartman
-
依托单位:
Exercise, MANF, and Chemical-Induced Neurodegeneration
-
批准号:10217454
-
项目类别:
-
资助金额:$18.31万
-
财政年份:2020
-
负责人:Jessica Helene Hartman
-
依托单位:
Exercise, MANF, and chemical-induced neurodegeneration
-
批准号:10020404
-
项目类别:
-
资助金额:$9.49万
-
财政年份:2019
-
负责人:Jessica Helene Hartman
-
依托单位:
Role of Mitochondrial CYP2E1 in Chemical Exposure-Driven Neurodegeneration
-
批准号:9319548
-
项目类别:
-
资助金额:$5.67万
-
财政年份:2016
-
负责人:Jessica Helene Hartman
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: